Fresenius Medical Care (FMS) said Tuesday it intends to launch a new share buyback program of about 1 billion euros ($1.16 billion) to be carried out in tranches over 12 months.
The company said the repurchase program is based on the authorization granted during the May 21 annual general meeting and is expected to start a few weeks after the completion of its previous buyback on April 30.
Shares of Fresenius Medical Care were up more than 1% in premarket activity Tuesday.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.